David Krasne

David Krasne has a diverse work experience spanning various leadership roles and industries. David co-founded RedNest Partners in 2016, where they currently serve as a Co-Founder and Partner. In 2012, they co-founded Sentire Medical Systems and ExpertConnect, where they held the positions of Director and Co-Founder, respectively. From 2010 to 2016, they served as the CEO and Director of American Medical Forensic Specialists. David is currently the Chief Financial Officer at Nanocan Therapeutics Corporation, a role they assumed in 2022. Additionally, they worked as a Director at Tecmotiv starting in 2019. Earlier in their career, they held positions such as Vice President at The Riverside Company and Chief Operating Officer at Professional Sports Publications. Prior to that, they served as a Principal at Merrill Lynch Global Private Equity, where they managed investments, executed transactions, and served on boards of directors. David started their career as an Investment Banking Analyst at Merrill Lynch & Co., focusing on valuation and merger and acquisition analyses in the Financial Institutions Group.

David Krasne's education history includes a Bachelor of Science degree in Finance and Accounting from Penn State University. David also pursued further education at the UCLA Anderson School of Management, where they obtained their MBA degree.